Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Trump’s drug pricing reforms lack bite

February 12, 2018 Sales and Marketing Drug pricing, President trump, Trump, biotech, drugs, pharma, pharmaceutical

President Trump’s rhetoric leading up to his election had the pharmaceutical industry very worried – his often quoted line about …
News

Boehringer terminates Alzheimer’s candidate after Phase 2 failure

February 12, 2018 Research and Development, Sales and Marketing Alzheimer's, Boehringer Ingelheim, dementia, pharma

Boehringer Ingelheim has announced its intention to halt development of its candidate BI 409306 in the treatment of Alzheimer’s after …
News

MannKind entices Lilly VP to CMO role

February 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Mannkind, biotech, drugs, pharma, pharmaceutical

MannKind, the California-based biotech, announced that David Kendall would be joining its team as Chief Medical Officer and would be …
Appointment

Top Ten most popular articles on Pharmafile.com this week

February 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Allergan, Antibiotics, Avycaz, Elastagen, FDA, GSK, India, J&J, JJ, Nektar Therapeutics, Novartis, Theravance, artificial intelligence, pharma

It’s top ten time again. This week, among our most popular stories was the worrying news that, accoridng to research …
News

FDA expands J&J Zytiga combo’s indication to include castration-sensitive prostate cancer

February 9, 2018 Medical Communications, Sales and Marketing Cancer, FDA, J&J, JJ, Janssen, Johnson & Johnson, Zytiga, pharma

Johnson & Johnson has announced that Zytiga (abiraterone acetate) in combination with prednisone has been awarded FDA approval in the …
News

Migraine drug bad news hits a weakened Teva

February 9, 2018 Medical Communications, Sales and Marketing CGRP, Teva, biotech, drugs, pharma, pharmaceutical

The cacophony of bad news that Teva has received in 2017 really needs no retelling, anyone following the story of …
News

Stada poaches Novartis exec for fifth CEO in two years

February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Stada, appointment

Stada has revealed its new CEO as Peter Goldschmidt, the current head of North American operations at Novartis’ generics and …
Appointment

Celgene Executive Chairman Bob Hugin retires

February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Fresh from its acquisition of Juno Therapeutics, Celgene announced that its Executive Chairman Bob Hugin was to retire effective 5 …
Appointment

New Year, new goals

February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer Research UK, Chiesi, EMA, FDA, Genetic Alliance, pharma

With the New Year begun in earnest, Pharmafocus speaks to a range of players in pharma and the life sciences …
Feature

Dr Reddy’s hit by yet another recall, of 80,000+ bottles

February 8, 2018 Sales and Marketing Dr Reddy's, FDA, biotech, drugs, pharma, pharmaceutical

Dr Reddy’s Laboratories problem with ensuring products reach the market at a quality the FDA deems acceptable is no secret …
News

FDA approves Gilead’s Biktarvy for HIV as Viiv Healthcare launches patent lawsuit

February 8, 2018 Sales and Marketing Biktarvy, FDA, GSK, Gilead, HIV, Pfizer, Shionogi, US, ViiV Healthcare, descovy, pharma

Gilead has announced that its daily single-tablet therapy Biktarvy has received FDA approval for HIV-1 infection.
News

Novartis tastes own medicine, Advair generic delayed

February 8, 2018 Sales and Marketing FDA, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis had not been frontrunner to receive approval for its generic version of GSK’s Advair – lagging behind Mylan’s generic …
News

Theravance seals potential $1bn deal with J&J

February 8, 2018 Sales and Marketing Johnson & Johnson, Theravance Biopharma, biotech, drugs, pharma, pharmaceutical

The JAK inhibitor field is beginning to heat up – AbbVie is soon to enter Phase 3 with its predicted …
News

Astellas confirms Kenji Yasukawa as new President and CEO

February 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, appointment

Japanese pharmaceutical firm Astellas has announced that its Board of Directors has approved the selection of current Chief Strategy Officer …
Appointment

CEO gets the axe: Arcturus relieve Payne of position

February 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arcturus, biotech, drugs, pharma, pharmaceutical

Early in February, Arcturus Therapeutics revealed that it had let its CEO, Joseph Payne, go and had replaced him as …
Appointment
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026